Abstract
The approach by medicine and associated sciences dealing with the pathologies produced by obesity and Type 2 diabetes (T2D) has predominantly focused on the treatment rather than the prevention of the two health conditions. Both pharmacological and surgical approaches have been used in the treatment of both obesity and T2D. None is completely successful without incurring substantial side-effects including the option of permanent changes to the gastro-intestinal anatomy and physiology. This review puts forward for consideration two ideas: (1) That some of the failures in addressing prevention of obesity and T2D are the result of incorrect characterization of the neuroendocrine control of feeding and regulation of body weight, and (2) that there is a knowledge gap in how the capacity of the pancreas and adipose tissue, key organs in the pathologies of obesity and T2D, may be modified during two important periods of tissue proliferation, the second trimester of fetal development, the pre-pubertal growth spurt, and also possibly during recovery from substantial weight loss.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
